BIOCONTROL TECHNOLOGY INC
8-K, 2000-06-02
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: TAX FREE INVESTMENTS CO, 497J, 2000-06-02
Next: KEMPER HIGH YIELD SERIES, N-30D, 2000-06-02



             SECURITIES AND EXCHANGE COMMISSION

                   Washington, D.C.  20549

                          FORM 8-K

                       CURRENT REPORT

           Pursuant to Section 13 or 15(d) of the
               Securities Exchange Act of 1934

                     ___________________


  Date of Report (Date of earliest event reported) June 2, 2000

                 BIOCONTROL TECHNOLOGY, INC.
   (Exact name of registrant as specified in its charter)


Pennsylvania                      0-10822                  25-1229323
(State of other jurisdiction  (Commission File Number)   (IRS Employer
  of incorporation)                                    Identification No.)


             2275 Swallow Hill Road, Bldg. 2500
               Pittsburgh, Pennsylvania 15220
   (Address of principal executive offices)           (Zip Code)


Registrant's telephone number, including area code (412) 349-1811


      Former address: 300 Indian Springs Road; Indiana,
                     Pennsylvania 15701
____________________________________________________________
                            _____
               (Former name or former address,
               if changes since last report.)












Item 1.   Change in Control of Registrant.
          Not applicable.

Item 2.   Acquisition or Disposition of Assets.
          Not applicable.

Item 3.   Bankruptcy or Receivership.
          Not applicable.

Item 4.   Changes in Registrant's Certifying Accountant
          Not applicable.

Item 5.   Other Events.

          Biocontrol Technology, Inc. announced today that
          it plans to change its name to BICO and will form
          a new division that will focus on the
          Corporation's biomedical projects.  The new
          division, which will retain the name Biocontrol
          Technology, will be headed by David L. Purdy and
          will be headquartered in Indiana, Pennsylvania.

Item 6.   Resignation of Registrant's Directors.

          David L. Purdy resigned as Chairman and a director
          of the Corporation in order to head its new
          division. (Resignation letter attached as an
          exhibit)

Item 7.   Financial Statement, Pro Forma Financial Information and Exhibits.

          (a)  Financial Statements and Businesses Acquired - Not Applicable.
          (b)  Pro Forma Financial Information - Not Applicable.
          (c)  Exhibits
               i.Press Release
               ii. David L. Purdy resignation letter


                           SIGNATURES

      Pursuant to the requirement of the Securities Exchange Act
of  1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.

                                   BIOCONTROL TECHNOLOGY, INC.

                                   by  /s/   Fred E. Cooper
                                             Fred E. Cooper, CEO
DATED:  June 2, 2000






                                              BICO
                                  BIOCONTROL TECHNOLOGY, INC
                       2275 Swallow Hill Road, Building 2500
                                       Pittsburgh, PA  15220
Press Release

Investors                                  Media
Diane McQuaide                             Susan Taylor
1.412.429.0673  phone                      1.412.429.0673 phone
1.412.279.9690  fax                        1.412.279.5041 fax



        BIOCONTROL TECHNOLOGY TO CHANGE NAME TO BICO;
             DAVID L. PURDY TO HEAD NEW DIVISION

     Pittsburgh,  PA - June 2, 2000 - Biocontrol Technology,
Inc. (OTCBB:BICO) announced today that the Company plans  to
change its name to BICO, and will create a new division that
will  retain  the  name  Biocontrol  Technology.   The   new
division,  which  will be headquartered at its  Indiana,  PA
location,  will  concentrate  on  the  Company's  biomedical
projects,   including   the   research,   development    and
manufacturing of the Company's biomedical products.
     The Company's Chairman, David L. Purdy, will resign his
position as a director and Chairman of the Board in order to
become  the President and CEO of the new division so he  can
focus  his  full-time efforts and energy  on  the  continued
development  and refinement of the Diasensor, the  Company's
noninvasive  glucose  sensor.    He  will  also  remain  the
Chairman of the Board of Diasensor.com, Inc.
      Biocontrol  Technology has its  corporate  offices  in
Pittsburgh,  PA  and  is  involved in  the  development  and
manufacture   of   biomedical  devices   and   environmental
products.  The company's subsidiaries include Diasensor.com,
ViaCirQ,  Inc.  and  Petrol Rem, Inc.  All  are  located  in
Pittsburgh, PA.



WEB SITE:  www.bico.com
INVESTOR RELATIONS NEWSLINE NUMBER:       1-800-357-6204
This press release contains statements of a forward-looking
nature.  Shareholders and potential investors are cautioned
  that such statements are predictions and actual events or
               results may vary significantly.
                             ###



                      1482 Ambrose Road
                   Marion Center, PA 15759
                        724-397-2779

                        June 1, 2000







To the Board of Directors of Biocontrol Technology, Inc.

Gentlemen:

Please accept my resignation as a member and Chairman of the
Board of Directors of Biocontrol Technology, Inc.

I am resigning in order to focus my efforts and energy on
our new division, Biocontrol Technology, and on our
biomedical products.

                              Sincerely,

                              /s/ David L. Purdy

                              David L. Purdy





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission